Paolo Vigneri
Paolo Vigneri
Verified email at unict.it
TitleCited byYear
Diabetes and cancer
P Vigneri, F Frasca, L Sciacca, G Pandini, R Vigneri
Endocrine-related cancer 16 (4), 1103-1123, 2009
10302009
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells
C Bellodi, MR Lidonnici, A Hamilton, GV Helgason, AR Soliera, ...
The Journal of clinical investigation 119 (5), 1109-1123, 2009
5512009
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Experts in Chronic Myeloid Leukemia
Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013
5382013
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
G Bunone, P Vigneri, L Mariani, S Butó, P Collini, S Pilotti, MA Pierotti, ...
The American journal of pathology 155 (6), 1967-1976, 1999
4881999
Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase
P Vigneri, JYJ Wang
Nature medicine 7 (2), 228-234, 2001
3842001
Iodide symporter gene expression in human thyroid tumors
F Arturi, D Russo, M Schlumberger, JA du Villard, B Caillou, P Vigneri, ...
The Journal of Clinical Endocrinology & Metabolism 83 (7), 2493-2496, 1998
2481998
RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
I Bongarzone, P Vigneri, L Mariani, P Collini, S Pilotti, MA Pierotti
Clinical Cancer Research 4 (1), 223-228, 1998
2151998
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
I Bongarzone, L Fugazzola, P Vigneri, L Mariani, P Mondellini, F Pacini, ...
The Journal of Clinical Endocrinology & Metabolism 81 (5), 2006-2009, 1996
2141996
Cancer stem cells and chemosensitivity
M Maugeri-Saccà, P Vigneri, R De Maria
Clinical Cancer Research 17 (15), 4942-4947, 2011
1712011
The changing epidemiology of thyroid cancer: why is incidence increasing?
R Vigneri, P Malandrino, P Vigneri
Current opinion in oncology 27 (1), 1-7, 2015
1692015
Vγ9Vδ2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells
M D’Asaro, C La Mendola, D Di Liberto, V Orlando, M Todaro, M Spina, ...
The Journal of Immunology 184 (6), 3260-3268, 2010
1402010
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma
D Russo, S Tumino, F Arturi, P Vigneri, G Grasso, A Pontecorvi, S Filetti, ...
The Journal of Clinical Endocrinology & Metabolism 82 (3), 735-738, 1997
1361997
Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland
S Pilotti, P Collini, L Mariani, M Placucci, I Bongarzone, P Vigneri, ...
The American journal of surgical pathology 21 (12), 1466-1473, 1997
1331997
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells
E Tirrò, ML Consoli, M Massimino, L Manzella, F Frasca, L Sciacca, ...
Cancer research 66 (8), 4263-4272, 2006
1302006
HMGA1 inhibits the function of p53 family members in thyroid cancer cells
F Frasca, A Rustighi, R Malaguarnera, S Altamura, P Vigneri, G Del Sal, ...
Cancer research 66 (6), 2980-2989, 2006
1052006
Obesity and cancer
P Vigneri, F Frasca, L Sciacca, L Frittitta, R Vigneri
Nutrition, Metabolism and Cardiovascular Diseases 16 (1), 1-7, 2006
832006
The insulin/IGF system in colorectal cancer development and resistance to therapy
PG Vigneri, E Tirrò, MS Pennisi, M Massimino, S Stella, C Romano, ...
Frontiers in oncology 5, 230, 2015
782015
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to hepatocyte growth factor
F Frasca, P Vigneri, V Vella, R Vigneri, JYJ Wang
Oncogene 20 (29), 3845-3856, 2001
752001
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
A Belfiore, A Costantino, F Frasca, G Pandini, R Mineo, P Vigneri, ...
Molecular endocrinology 10 (11), 1318-1326, 1996
701996
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic …
M Breccia, R Latagliata, F Stagno, L Luciano, A Gozzini, F Castagnetti, ...
Haematologica 96 (10), 1457-1461, 2011
692011
The system can't perform the operation now. Try again later.
Articles 1–20